Abstract
Purpose of Review
This paper provides a review of the diagnostic evaluation of both microscopic and gross hematuria, as well as an update on the pathogenesis, clinical features, and treatment strategies for several diseases of the kidneys and urinary tract in which hematuria is a prominent finding. The goal is to provide pediatric providers with a framework through which appropriate and expeditious referral to subspecialty care may be made for definitive treatment.
Recent Findings
Although there has been great heterogeneity in published treatment strategies for many causes of hematuria, the Kidney Diseases Improving Global Outcomes (KDIGO) initiative has recently set forth guidelines for glomerular diseases in particular to provide evidence-based strategies for treatment. In addition, recent advances in the understanding of molecular pathogenesis and long-term clinical outcomes for other non-glomerular diseases have led to updates in treatment strategies summarized in this review.
Summary
As the pediatric primary care provider is often the first point of contact for children with microscopic or gross hematuria, updated knowledge as to the epidemiology and management of several of the various causes of hematuria will improve the care of children by both avoiding extraneous testing and interventions and implementing definitive care (either by expectant management and reassurance or by subspecialty referral) in a timely manner.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Dodge WF, West EF, Smith EH, Bunce H. Proteinuria and hematuria in schoolchildren: epidemiology and early natural history. J Pediatr. 1976;88(2):327–47.
Vehaskari VM, Rapola J, Koskimies O, Savilahti E, Vilska J, Hallman N. Microscopic hematuria in schoolchildren: epidemiology and clinicopathologic evaluation. J Pediatr. 1979;95(5):676–84.
Massengill SF. Hematuria. Pediatr Rev. 2008;29(10):342–8.
Yap H, Lau P. Hematuria and proteinuria. Second ed. Pediatric Kidney Disease. Springer; 2016.
Ingelfinger JR, Davis AE, Grupe WE. Frequency and etiology of gross hematuria in a general pediatric setting. Pediatrics. 1977;59(4):557–61.
Mazouz B, Almagor M. False-positive microhematuria in dipsticks urinalysis caused by the presence of semen in urine. Clin Biochem. 2003;36(3):229–31.
Grossfeld GD, Litwin MS, Wolf JS Jr, Hricak H, Shuler CL, Agerter DC, et al. Evaluation of asymptomatic microscopic hematuria in adults: the American Urological Association best practice policy—part I: definition, detection, prevalence, and etiology 1. Urology. 2001;57(4):599–603.
Simerville JA, Maxted WC, Pahira JJ. Urinalysis: a comprehensive review. Am Fam Physician. 2005;71(6):1153–62.
Pearcy RM, Mitchell SC, Smith RL. Beetroot and red urine. Portland Press Limited; 1992.
Patel HP, Bissler JJ. Hematuria in children. Pediatr Clin. 2001;48(6):1519–37.
Greenfield SP, Williot P, Kaplan D. Gross hematuria in children: a ten-year review. Urology. 2007;69(1):166–9.
Jackson EC. Urinary tract infections in children: knowledge updates and a salute to the future. Pediatr Rev. 2015;36(4):153–64. quiz 65–6
Asghar M, Ahmed K, Shah S, Siddique M, Dasgupta P, Khan M. Renal vein thrombosis. Eur J Vasc Endovasc Surg. 2007;34(2):217–23.
Siddiqui WJ, Bakar A, Aslam M, Arif H, Bianco BA, Trebelev AE, et al. Left renal vein compression syndrome: cracking the nut of clinical dilemmas–three cases and review of literature. Am J Case Rep. 2017;18:754–9.
Ananthan K, Onida S, Davies A. Nutcracker syndrome: an update on current diagnostic criteria and management guidelines. Eur J Vasc Endovasc Surg. 2017;53:886–94.
Raghavan R, Eknoyan G. Acute interstitial nephritis—a reappraisal and update. Clin Nephrol. 2014;82(3):149–62.
West CD. Asymptomatic hematuria and proteinuria in children: causes and appropriate diagnostic studies. J Pediatr. 1976;89(2):173–82.
Meyers KE. Evaluation of hematuria in children. Urol Clin N Am. 2004;31(3):559–73.
Yap H, Quek C, Shen Q, Joshi V, Chia K. Role of urinary screening programmes in children in the prevention of chronic kidney disease. Ann Acad Med Singap. 2005;34(1):3–7.
Murakami M, Yamamoto H, Ueda Y, Murakami K, Yamauchi K. Urinary screening of elementary and junior high-school children over a 13-year period in Tokyo. Pediatr Nephrol. 1991;5(1):50–3.
Davin J-C, Coppo R. Henoch–Schönlein purpura nephritis in children. Nat Rev Nephrol. 2014;10(10):563–73.
Lehman TJ. A practical guide to systemic lupus erythematosus. Pediatr Clin N Am. 1995;42(5):1223–38.
Kruegel J, Rubel D, Gross O. Alport syndrome—insights from basic and clinical research. Nat Rev Nephrol. 2013;9(3):170–8.
Kashtan CE. Alport syndrome and thin glomerular basement membrane disease. J Am Soc Nephrol. 1998;9(9):1736–50.
Nath KA, Hebbel RP. Sickle cell disease: renal manifestations and mechanisms. Nat Rev Nephrol. 2015;11(3):161–71.
Fogazzi GB, Edefonti A, Garigali G, Giani M, Zolin A, Raimondi S, et al. Urine erythrocyte morphology in patients with microscopic haematuria caused by a glomerulopathy. Pediatr Nephrol. 2008;23(7):1093–100.
Omoloja AA, Patel H, Ey E, Jackson E. Common renal problems in pediatric medicine. Curr Probl Pediatr Adolesc Health Care. 2007;37(5):153–94.
•• Hernandez JD, Ellison JS, Lendvay TS. Current trends, evaluation, and management of pediatric nephrolithiasis. JAMA Pediatr. 2015;169(10):964–70. This recent review provides a comprehensive update on the epidemiology, metabolic evaluation, and management of nephrolithasis in children.
Tasian GE, Ross ME, Song L, Sas DJ, Keren R, Denburg MR, et al. Annual incidence of nephrolithiasis among children and adults in South Carolina from 1997 to 2012. Clin J Am Soc Nephrol. 2016;11(3):488–96.
Claes DJ, Jackson E. Cystinuria: mechanisms and management. Pediatr Nephrol. 2012;27(11):2031–8.
Copelovitch L. Urolithiasis in children: medical approach. Pediatr Clin. 2012;59(4):881–96.
Evan AP. Physiopathology and etiology of stone formation in the kidney and the urinary tract. Pediatr Nephrol. 2010;25(5):831–41.
Teichman JM. Acute renal colic from ureteral calculus. N Engl J Med. 2004;350(7):684–93.
Borghi L, Schianchi T, Meschi T, Guerra A, Allegri F, Maggiore U, et al. Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med. 2002;346(2):77–84.
Srivastava A, Patel N. Autosomal dominant polycystic kidney disease. Am Fam Physician. 2014;90(5).
Malkan AD, Loh A, Bahrami A, Navid F, Coleman J, Green DM, et al. An approach to renal masses in pediatrics. Pediatrics. 2015;135(1):142–58.
Howlader N, Noone A, Krapcho M, Garshell J, Neyman N, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975–2010, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2010/, based on November 2012 SEER data submission, posted to the SEER web site, April 2013.
Fischbach BV, Trout KL, Lewis J, Luis CA, Sika M. WAGR syndrome: a clinical review of 54 cases. Pediatrics. 2005;116(4):984–8.
Castellino SM, McLean TW. Pediatric genitourinary tumors. Curr Opin Oncol. 2007;19(3):248–53.
Weis SM, Cheresh DA. Tumor angiogenesis: molecular pathways and therapeutic targets. Nat Med. 2011;17(11):1359–70.
Escobar MA. Bleeding in the patient with a malignancy. Cancer. 2012;118(2):312–20.
O’Connor OJ, McSweeney SE, Maher MM. Imaging of hematuria. Radiol Clin N Am. 2008;46(1):113–32.
Fallat M, Hutter J. American Academy of Pediatrics section on hematology oncology, American Academy of Pediatrics section on surgery. Preservation of fertility in pediatric and adolescent patients with cancer. Pediatrics. 2008;121(5):e1461–9.
Becker AM. Sickle cell nephropathy: challenging the conventional wisdom. Pediatr Nephrol. 2011;26(12):2099–109.
Pham P-TT, Pham P-CT, Wilkinson AH, Lew SQ. Renal abnormalities in sickle cell disease. Kidney Int. 2000;57(1):1–8.
Naik RP, Derebail VK. The spectrum of sickle hemoglobin-related nephropathy: from sickle cell disease to sickle trait. Expert Rev Hematol. 2017;10(12):1087–94.
Alves FR, FdAQ R. Revision about hearing loss in the Alport’s syndrome, analyzing the clinical, genetic and bio-molecular aspects. Rev Bras Otorrinolaringol. 2005;71(6):813–9.
Kashtan CE. Alport syndrome and thin basement membrane nephropathy. 2001 Aug 28 [Updated 2015 Nov 25]. In: Adam MP AH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2018. Available from: https://www.ncbi.nlm.nih.gov/books/NBK1207/.
Mehta L, Jim B, editors. Hereditary renal diseases. Semin Nephrol; 2017: Elsevier.
Tarr PI, Gordon CA, Chandler WL. Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet. 2005;365(9464):1073–86.
Garg AX, Suri RS, Barrowman N, Rehman F, Matsell D, Rosas-Arellano MP, et al. Long-term renal prognosis of diarrhea-associated hemolytic uremic syndrome: a systematic review, meta-analysis, and meta-regression. JAMA. 2003;290(10):1360–70.
Scheiring J, Andreoli SP, Zimmerhackl LB. Treatment and outcome of Shiga-toxin-associated hemolytic uremic syndrome (HUS). Pediatr Nephrol. 2008;23(10):1749–60.
Chang SL, Shortliffe LD. Pediatric urinary tract infections. Pediatr Clin N Am. 2006;53(3):379–400.
Boeckh M, Erard V, Zerr D, Englund J. Emerging viral infections after hematopoietic cell transplantation. Pediatr Transplant. 2005;9(s7):48–54.
Mufson MA, Belshe RB, Horrigan TJ, Zollar LM. Cause of acute hemorrhagic cystitis in children. Am J Dis Child. 1973;126(5):605–9.
Mulvey MA. Adhesion and entry of uropathogenic Escherichia coli. Cell Microbiol. 2002;4(5):257–71.
Semeniuk H, Church D. Evaluation of the leukocyte esterase and nitrite urine dipstick screening tests for detection of bacteriuria in women with suspected uncomplicated urinary tract infections. J Clin Microbiol. 1999;37(9):3051–2.
Meglič A, Čavić M, Hren-Vencelj H, Tršinar B, Ravnik M, Kenda R. Chlamydial infection of the urinary tract in children and adolescents with hematuria. Pediatr Nephrol. 2000;15(1–2):132–3.
Gauthier M, Gouin S, Phan V, Gravel J. Association of malodorous urine with urinary tract infection in children aged 1 to 36 months. Pediatrics. 2012;129(5):885–90.
Brandström P, Esbjörner E, Herthelius M, Swerkersson S, Jodal U, Hansson S. The Swedish reflux trial in children: III. Urinary tract infection pattern. J Urol. 2010;184(1):286–91.
Investigators RT. Antimicrobial prophylaxis for children with vesicoureteral reflux. N Engl J Med. 2014;370(25):2367–76.
Ahn S-Y, Ingulli E. Acute poststreptococcal glomerulonephritis: an update. Curr Opin Pediatr. 2008;20(2):157–62.
Eison TM, Ault BH, Jones DP, Chesney RW, Wyatt RJ. Post-streptococcal acute glomerulonephritis in children: clinical features and pathogenesis. Pediatr Nephrol. 2011;26(2):165–80.
Kanjanabuch T, Kittikowit W, Eiam-Ong S. An update on acute postinfectious glomerulonephritis worldwide. Nat Rev Nephrol. 2009;5(5):259–69.
Sjöholm AG. Complement components and complement activation in acute poststreptococcal glomerulonephritis. Int Arch Allergy Immunol. 1979;58(3):274–84.
Rodriguez-Iturbe B, Musser JM. The current state of poststreptococcal glomerulonephritis. J Am Soc Nephrol. 2008;19(10):1855–64.
Zoch-Zwierz W, Wasilewska A, Biernacka A, Tomaszewska B, Winiecka W, Wierciński R, et al. The course of post-streptococcal glomerulonephritis depending on methods of treatment for the preceding respiratory tract infection. Wiad Lek. 2001;54(1–2):56–63.
Roy S, Murphy WM, Arant BS. Poststreptococcal crescenteric glomerulonephritis in children: comparison of quintuple therapy versus supportive care. J Pediatr. 1981;98(3):403–10.
Wong W, Morris MC, Zwi J. Outcome of severe acute post-streptococcal glomerulonephritis in New Zealand children. Pediatr Nephrol. 2009;24(5):1021–6.
Coppo R, editor. Pediatric IgA nephropathy: clinical and therapeutic perspectives. Semin Nephrol; 2008: Elsevier.
Yuzawa Y, Yamamoto R, Takahashi K, Katafuchi R, Tomita M, Fujigaki Y, et al. Evidence-based clinical practice guidelines for IgA nephropathy 2014. Clin Exp Nephrol. 2016;20(4):511–35.
Tomino Y, Suzuki S, Imai H, Saito T, Kawamura T, Yorioka N, et al. Measurement of serum IgA and C3 may predict the diagnosis of patients with IgA nephropathy prior to renal biopsy. J Clin Lab Anal. 2000;14(5):220–3.
Cattran DC, Coppo R, Cook HT, Feehally J, Roberts IS, Troyanov S, et al. The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification. Kidney Int. 2009;76(5):534–45.
• Trimarchi H, Barratt J, Cattran DC, Cook HT, Coppo R, Haas M, et al. Oxford classification of IgA nephropathy 2016: an update from the IgA nephropathy classification working group. Kidney Int. 2017;91(5):1014–21. This article adds new understanding as to the implications of histopathological characteristics in IgA nephropathy, specifially the prognostic significance of crescentic disease.
Xu K, Zhang L, Ding J, Wang S, Su B, Xiao H et al. Value of the Oxford classification of IgA nephropathy in children with Henoch–Schönlein purpura nephritis. J Nephrol. 2017:1–8.
•• Cattran DC, Feehally J, Cook HT, Liu ZH, Fervenza FC, Mezzano SA, et al. Kidney disease: improving global outcomes (KDIGO) glomerulonephritis work group. KDIGO clinical practice guideline for glomerulonephritis. Kidney Int Suppl. 2012;2(2):139–274. This set of practice guidelines describes the evidence-based consensus guidelines for diagnostic evaluation and treatment of several forms of glomerulonephritis with additional pediatric-focused recommendations.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
O. N. Ray Bignall II and Bradley P. Dixon declare no conflicts of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
This article is part of the Topical Collection on Urology
Rights and permissions
About this article
Cite this article
Bignall, O.R., Dixon, B.P. Management of Hematuria in Children. Curr Treat Options Peds 4, 333–349 (2018). https://doi.org/10.1007/s40746-018-0134-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40746-018-0134-z